Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
D000367:Age Factors; D001593:Benzyl Compounds; D001714:Bipolar Disorder / Q000150:complications / Q000201:enzymology; D001792:Blood Platelets / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D001921:Brain / Q000201:enzymology; D003486:Cyanides / Q000494:pharmacology; D004200:Diseases in Twins; D005260:Female; D006579:Heterozygote; D006801:Humans; D007490:Iproniazid / Q000494:pharmacology; D007538:Isoniazid / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008928:Mitochondria / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000097:blood / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009928:Organ Specificity; D010293:Pargyline / Q000494:pharmacology; D010949:Plasma / Q000187:drug effects / Q000201:enzymology*; D011247:Pregnancy; D012559:Schizophrenia / Q000150:complications / Q000201:enzymology; D012737:Sex Factors; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines; D014427:Twins; D014439:Tyramine
D001593:Benzyl Compounds; D003486:Cyanides; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D014191:Tranylcypromine; D010293:Pargyline; D007490:Iproniazid; D008995:Monoamine Oxidase; D007538:Isoniazid; D014439:Tyramine